ENTRY       D12322                      Drug
NAME        Crexavibart (USAN/INN)
FORMULA     C6490H9992N1728O2064S42
EXACT_MASS  146503.8304
MOL_WEIGHT  146593.8487
SEQUENCE    (Heavy chain)
            EVQLVESGGG LIQPGGSLRL SCAASGFTVS NNYMSWVRQA PGKGLEWVSV IYSGGSTYYA
            DSVKGRFTIS RDKSKNTLYL QMNSLRAEDT AVYYCAREGE VEGYNDFWSG YSRDRYYFDY
            WGQGTLVTVS SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG
            VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKRVE PKSCDKTHTC
            PPCPAPELLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN
            AKTKPREEQY NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP
            QVYTLPPSRE EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL
            YSKLTVDKSR WQQGNVFSCS VLHEALHSHY TQKSLSLSPG
            (Light chain)
            QSALTQPASV SGSPGQSITI SCTGTSSDVG GYNYVSWYQQ HPGKAPKLMI YDVSNRPSGV
            SNRFSGSKSG NTASLTISGL QAEDEADYYC SSYTSSSTRV FGTGTKVTVL GQPKAAPSVT
            LFPPSSEELQ ANKATLVCLI SDFYPGAVTV WKADSSPVK AGVETTTPSK QSNNKYAASS
            YLSLTPEQWK SHRSYSCQVT HEGSTVEKTV APTECS
            (Disulfide bridge: H22-H95, H158-H214, H234-L215, H240-H'240, H243-H'243, H275-H335, H381-H439, H'22-H'95, H'158-H'214, H'234-L'215, H'275-H'335, H'381-H'439, L22-L90, L138-L197, L'22-L'90, L'138-L'197)
  TYPE      Peptide
CLASS       Antiviral
             DG03174  Anti-SARS-CoV-2 agent
EFFICACY    Antiviral
  TYPE      Monoclonal antibody
COMMENT     Treatment of SARS-CoV-2 infection
TARGET      SARS-CoV-2 spike glycoprotein [KO:K24152]
  PATHWAY   ko03230(K24152)  Viral genome structure
            ko05171(K24152)  Coronavirus disease - COVID-19
BRITE       Drug groups [BR:br08330]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               D12322  Crexavibart
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Coronavirus spike protein
                D12322  Crexavibart (USAN/INN)
DBLINKS     CAS: 2599039-61-7
///
